10:15AM – 11:15AM
PANEL DISCUSSION: Consider the Future of the Sunshine Act Under the New Administration
Avi Spira, Vice President and Chief Compliance Officer, CANTEL MEDICAL CORP.
Richard Velardi, Compliance Manager, Transparency and Reporting, SUN PHARMA
Donna White, Vice President, Contracts and Compliance, CHIESI USA, INC.
- Deliberate the impact of possible changes to the GOP executive branch, GOP legislative branch, CMS and DOJ enforcement
- Discuss what the potential dismantling of the Affordable Care Act means for national and global open payment reporting
- Examine the 21st Century Cures Act and how its enforcement will affect the way transparency is regulated